|Bid||189.45 x 800|
|Ask||189.19 x 1000|
|Day's Range||183.04 - 190.60|
|52 Week Range||124.60 - 231.36|
|Beta (5Y Monthly)||1.00|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||1.88 (1.02%)|
|Ex-Dividend Date||Jun 15, 2020|
|1y Target Est||N/A|
Shares of cleaning and sanitizing giant Ecolab (NYSE: ECL) lost nearly 9% of their value on Tuesday following its release of second-quarter 2020 earnings. While COVID-19-related demand boosted Ecolab's healthcare and life sciences segment revenue, the momentum wasn't enough to offset weakness in other major business lines. Ecolab's revenue declined 15% against the prior-year period to $2.7 billion, while net income plunged from a profit of $369 million to a loss of $2 billion.
ECL earnings call for the period ending June 30, 2020.
Ecolab's (ECL) second-quarter results reflect weakness in the Global Industrial and Institutional segments.